| Literature DB >> 21889412 |
Sander van Assen1, Aalzen de Haan, Albert Holvast, Gerda Horst, Linda Gorter, Johanna Westra, Cees G M Kallenberg, Denise S C Telgt, Abraham M Palache, Katinka M Giezeman, Marc Bijl.
Abstract
Influenza-specific cell-mediated immune (CMI) responses can protect from influenza, but may be decreased in CVID-patients since defects in CMI responses have been demonstrated in CVID-patients. Therefore CMI responses were evaluated in 15 CVID-patients and 15 matched healthy controls (HC) by determining frequencies of interferon (IFN)γ-producing PBMC, and frequencies of IFNγ-, interleukin (IL)-2- and tumour necrosis factor (TNF)α-producing CD4+ and CD8+ T-cells before and after influenza vaccination using IFNγ enzyme-linked immunospot (IFNγ-ELISpot) and flow cytometry. Humoral responses were determined using haemagglutination inhibition assay. In CVID-patients the number of spotforming PBMC in the IFNγ-ELISpot did not increase following influenza vaccination, in contrast to HC. In flow cytometry, the frequencies of IFNγ-producing T-cells decreased in CVID-patients after influenza vaccination, while in HC the frequencies of IFNγ-production flow cytometry increased. Concluding, CMI responses following influenza vaccination are hampered in CVID-patients compared to HC. Additional protective strategies against influenza other than vaccination are warranted.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21889412 DOI: 10.1016/j.clim.2011.07.004
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969